Skip to content
healthcare.dev

Ondansetron

NDC 76420-217, Ondansetron, tablet, orally disintegrating, from Asclemed USA, Inc..

Product NDC
76420-217
Status
Listed
Labeler
Asclemed USA, Inc.
Dosage form
TABLET, ORALLY DISINTEGRATING
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA090469
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/76420-217 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ONDANSETRON4 mg/1

Pharmacologic classes

Serotonin 3 Receptor Antagonists [MoA]; Serotonin-3 Receptor Antagonist [EPC]

Package NDCNDC-11Package
76420-217-04764200217044 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (76420-217-04)
76420-217-06764200217066 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (76420-217-06)
76420-217-107642002171010 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (76420-217-10)
76420-217-207642002172020 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (76420-217-20)
76420-217-30764200217303 BLISTER PACK in 1 CARTON (76420-217-30) / 10 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/e436e361-da0f-7d6d-e053-2995a90a10e4

Use it

Look up 76420-217 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/76420-217 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 76420-217. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.